Selected research
Industry Research
Oxytocin Industry Research Report 2026
Market perspective
The global Oxytocin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oxytocin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oxytocin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oxytocin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oxytocin include Tianjin Biochem Pharmaceutical, Shanghai Harvest Pharmaceutical, Novartis, Nanjing Xinbai Pharmaceutical, Mylan, Pfizer, GSK, Chengdu Hepatunn and Anhui Hongye Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oxytocin market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oxytocin Market by Company
Tianjin Biochem Pharmaceutical
Shanghai Harvest Pharmaceutical
Novartis
Nanjing Xinbai Pharmaceutical
Mylan
Pfizer
GSK
Chengdu Hepatunn
Anhui Hongye Pharmaceutical
Suzhou Tianji Bio-Pharmaceutical
SPH NO.1 Biochemical & Pharmaceutical
Shanghai Ceneral Pharmaceutical
Ningbo Renjian Pharmaceutical Group
Hybio Pharmaceutical
Grindeks
Oxytocin Segment by Type
Injection
Nasal Spray
Oxytocin Segment by Application
For Baby Born
For Comestic
Others
Oxytocin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxytocin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxytocin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxytocin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oxytocin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oxytocin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oxytocin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Nasal Spray
Applications
- For Baby Born
- For Comestic
- Others
Companies covered
- Tianjin Biochem Pharmaceutical
- Shanghai Harvest Pharmaceutical
- Novartis
- Nanjing Xinbai Pharmaceutical
- Mylan
- Pfizer
- GSK
- Chengdu Hepatunn
- Anhui Hongye Pharmaceutical
- Suzhou Tianji Bio-Pharmaceutical
- SPH NO.1 Biochemical & Pharmaceutical
- Shanghai Ceneral Pharmaceutical
- Ningbo Renjian Pharmaceutical Group
- Hybio Pharmaceutical
- Grindeks
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oxytocin Market Size (2021-2032)
- 2.2.2 Global Oxytocin Sales (2021-2032)
- 2.2.3 Global Oxytocin Market Average Price (2021-2032)
- 2.3 Oxytocin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Nasal Spray
- 2.4 Oxytocin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 For Baby Born
- 2.4.3 For Comestic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oxytocin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oxytocin Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Oxytocin Revenue of Manufacturers (2021-2026)
- 3.4 Global Oxytocin Average Price by Manufacturers (2021-2026)
- 3.5 Global Oxytocin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oxytocin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oxytocin, Product Type & Application
- 3.8 Global Manufacturers of Oxytocin, Established Date
- 3.9 Global Oxytocin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Tianjin Biochem Pharmaceutical
- 4.1.1 Tianjin Biochem Pharmaceutical Company Information
- 4.1.2 Tianjin Biochem Pharmaceutical Business Overview
- 4.1.3 Tianjin Biochem Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Tianjin Biochem Pharmaceutical Oxytocin Product Portfolio
- 4.1.5 Tianjin Biochem Pharmaceutical Recent Developments
- 4.2 Shanghai Harvest Pharmaceutical
- 4.2.1 Shanghai Harvest Pharmaceutical Company Information
- 4.2.2 Shanghai Harvest Pharmaceutical Business Overview
- 4.2.3 Shanghai Harvest Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Harvest Pharmaceutical Oxytocin Product Portfolio
- 4.2.5 Shanghai Harvest Pharmaceutical Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Oxytocin Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Nanjing Xinbai Pharmaceutical
- 4.4.1 Nanjing Xinbai Pharmaceutical Company Information
- 4.4.2 Nanjing Xinbai Pharmaceutical Business Overview
- 4.4.3 Nanjing Xinbai Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nanjing Xinbai Pharmaceutical Oxytocin Product Portfolio
- 4.4.5 Nanjing Xinbai Pharmaceutical Recent Developments
- 4.5 Mylan
- 4.5.1 Mylan Company Information
- 4.5.2 Mylan Business Overview
- 4.5.3 Mylan Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan Oxytocin Product Portfolio
- 4.5.5 Mylan Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Oxytocin Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 GSK
- 4.7.1 GSK Company Information
- 4.7.2 GSK Business Overview
- 4.7.3 GSK Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GSK Oxytocin Product Portfolio
- 4.7.5 GSK Recent Developments
- 4.8 Chengdu Hepatunn
- 4.8.1 Chengdu Hepatunn Company Information
- 4.8.2 Chengdu Hepatunn Business Overview
- 4.8.3 Chengdu Hepatunn Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Chengdu Hepatunn Oxytocin Product Portfolio
- 4.8.5 Chengdu Hepatunn Recent Developments
- 4.9 Anhui Hongye Pharmaceutical
- 4.9.1 Anhui Hongye Pharmaceutical Company Information
- 4.9.2 Anhui Hongye Pharmaceutical Business Overview
- 4.9.3 Anhui Hongye Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Anhui Hongye Pharmaceutical Oxytocin Product Portfolio
- 4.9.5 Anhui Hongye Pharmaceutical Recent Developments
- 4.10 Suzhou Tianji Bio-Pharmaceutical
- 4.10.1 Suzhou Tianji Bio-Pharmaceutical Company Information
- 4.10.2 Suzhou Tianji Bio-Pharmaceutical Business Overview
- 4.10.3 Suzhou Tianji Bio-Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Suzhou Tianji Bio-Pharmaceutical Oxytocin Product Portfolio
- 4.10.5 Suzhou Tianji Bio-Pharmaceutical Recent Developments
- 4.11 SPH NO.1 Biochemical & Pharmaceutical
- 4.11.1 SPH NO.1 Biochemical & Pharmaceutical Company Information
- 4.11.2 SPH NO.1 Biochemical & Pharmaceutical Business Overview
- 4.11.3 SPH NO.1 Biochemical & Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 SPH NO.1 Biochemical & Pharmaceutical Oxytocin Product Portfolio
- 4.11.5 SPH NO.1 Biochemical & Pharmaceutical Recent Developments
- 4.12 Shanghai Ceneral Pharmaceutical
- 4.12.1 Shanghai Ceneral Pharmaceutical Company Information
- 4.12.2 Shanghai Ceneral Pharmaceutical Business Overview
- 4.12.3 Shanghai Ceneral Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Shanghai Ceneral Pharmaceutical Oxytocin Product Portfolio
- 4.12.5 Shanghai Ceneral Pharmaceutical Recent Developments
- 4.13 Ningbo Renjian Pharmaceutical Group
- 4.13.1 Ningbo Renjian Pharmaceutical Group Company Information
- 4.13.2 Ningbo Renjian Pharmaceutical Group Business Overview
- 4.13.3 Ningbo Renjian Pharmaceutical Group Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Ningbo Renjian Pharmaceutical Group Oxytocin Product Portfolio
- 4.13.5 Ningbo Renjian Pharmaceutical Group Recent Developments
- 4.14 Hybio Pharmaceutical
- 4.14.1 Hybio Pharmaceutical Company Information
- 4.14.2 Hybio Pharmaceutical Business Overview
- 4.14.3 Hybio Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Hybio Pharmaceutical Oxytocin Product Portfolio
- 4.14.5 Hybio Pharmaceutical Recent Developments
- 4.15 Grindeks
- 4.15.1 Grindeks Company Information
- 4.15.2 Grindeks Business Overview
- 4.15.3 Grindeks Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Grindeks Oxytocin Product Portfolio
- 4.15.5 Grindeks Recent Developments
5 Global Oxytocin Market Scenario by Region
- 5.1 Global Oxytocin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oxytocin Sales by Region: 2021-2032
- 5.2.1 Global Oxytocin Sales by Region: 2021-2026
- 5.2.2 Global Oxytocin Sales by Region: 2027-2032
- 5.3 Global Oxytocin Revenue by Region: 2021-2032
- 5.3.1 Global Oxytocin Revenue by Region: 2021-2026
- 5.3.2 Global Oxytocin Revenue by Region: 2027-2032
- 5.4 North America Oxytocin Market Facts & Figures by Country
- 5.4.1 North America Oxytocin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oxytocin Sales by Country (2021-2032)
- 5.4.3 North America Oxytocin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Oxytocin Market Facts & Figures by Country
- 5.5.1 Europe Oxytocin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oxytocin Sales by Country (2021-2032)
- 5.5.3 Europe Oxytocin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Oxytocin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oxytocin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oxytocin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oxytocin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oxytocin Market Facts & Figures by Country
- 5.7.1 South America Oxytocin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oxytocin Sales by Country (2021-2032)
- 5.7.3 South America Oxytocin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Oxytocin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oxytocin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oxytocin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oxytocin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Oxytocin Sales by Type (2021-2032)
- 6.1.1 Global Oxytocin Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Oxytocin Sales Market Share by Type (2021-2032)
- 6.2 Global Oxytocin Revenue by Type (2021-2032)
- 6.2.1 Global Oxytocin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oxytocin Revenue Market Share by Type (2021-2032)
- 6.3 Global Oxytocin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oxytocin Sales by Application (2021-2032)
- 7.1.1 Global Oxytocin Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Oxytocin Sales Market Share by Application (2021-2032)
- 7.2 Global Oxytocin Revenue by Application (2021-2032)
- 7.2.1 Global Oxytocin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oxytocin Revenue Market Share by Application (2021-2032)
- 7.3 Global Oxytocin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oxytocin Value Chain Analysis
- 8.1.1 Oxytocin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oxytocin Production Mode & Process
- 8.2 Oxytocin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oxytocin Distributors
- 8.2.3 Oxytocin Customers
9 Global Oxytocin Analyzing Market Dynamics
- 9.1 Oxytocin Industry Trends
- 9.2 Oxytocin Industry Drivers
- 9.3 Oxytocin Industry Opportunities and Challenges
- 9.4 Oxytocin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst